Suppr超能文献

用于经桡动脉冠状动脉介入治疗的Guidezilla™ I型引导延长导管。

Guidezilla™ guide extension catheter I for transradial coronary intervention.

作者信息

Lei Xinjun, Liang Qi, Fang Yuan, Xiao Yihui, Wang Dongqi, Dong Maozhi, Li Jiancheng, Yu Ting

机构信息

Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Department of Cardiovascular Medicine, Shangnan People's Hospital, Shangluo, China.

出版信息

Front Cardiovasc Med. 2022 Aug 17;9:931373. doi: 10.3389/fcvm.2022.931373. eCollection 2022.

Abstract

BACKGROUND

Percutaneous coronary intervention (PCI) is the preferred treatment method for coronary artery diseases (CAD). This study aimed to evaluate the effectiveness and complications of the Guidezilla™ guide extension catheter I (GGEC I) in transradial coronary intervention (TRI).

METHODS

This case series study included patients with CAD who underwent TRI using the GGEC I between August 2016 and January 2019 at the First Affiliated Hospital of Xi'an Jiaotong University.

RESULTS

A total of 221 patients aged 65.1 ± 9.26 years were included. Coronary angiography results indicated that most patients (77.8%) had triple-vessel lesions, including 47.5% with chronic total occlusion (CTO). A total of 237 target lesions were treated, most being type C lesions (95.8%). The most common indication for GGEC I use was heavy calcification (67%), followed by extreme tortuosity (12.2%), extreme tortuosity and heavy calcification (10.9%), distally located lesion (4.5%), picking up the retrograde wire (3.2%), anomalous vessel origin (1.8%), and releasing the burr incarceration (0.4%). The mean operation time was 58 min, and the overall success rate was 94.1%. Four patients received a drug-coated balloon. No significant differences were found in operation time and success rate among the low (<23), intermediate (23-32), and severe (>32) CAD groups based on SYNTAX score stratification ( > 0.05). Two subacute thrombosis cases each were reported perioperatively, during hospitalization, and at the 1-month follow-up.

CONCLUSION

The GGEC I might have advantages for TRI and is unaffected by SYNTAX score stratification.

摘要

背景

经皮冠状动脉介入治疗(PCI)是冠状动脉疾病(CAD)的首选治疗方法。本研究旨在评估Guidezilla™ 导引导管延长管I型(GGEC I)在经桡动脉冠状动脉介入治疗(TRI)中的有效性和并发症。

方法

本病例系列研究纳入了2016年8月至2019年1月在西安交通大学第一附属医院使用GGEC I进行TRI的CAD患者。

结果

共纳入221例年龄为65.1±9.26岁的患者。冠状动脉造影结果显示,大多数患者(77.8%)有三支血管病变,其中47.5%为慢性完全闭塞(CTO)。共治疗了237个靶病变,大多数为C型病变(95.8%)。使用GGEC I的最常见指征是重度钙化(67%),其次是极度迂曲(12.2%)、极度迂曲合并重度钙化(10.9%)、病变位于远端(4.5%)、拾起逆行导丝(3.2%)、血管起源异常(1.8%)和解除球囊嵌顿(0.4%)。平均手术时间为58分钟,总体成功率为94.1%。4例患者接受了药物涂层球囊治疗。根据SYNTAX评分分层,低(<23)、中(23 - 32)、重度(>32)CAD组在手术时间和成功率方面无显著差异(P>0.05)。围手术期、住院期间及1个月随访时各报告了2例亚急性血栓形成病例。

结论

GGEC I在TRI中可能具有优势,且不受SYNTAX评分分层的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a969/9428470/6f89ec439301/fcvm-09-931373-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验